About
Marc Lohrmann has joined Vesalius Biocapital in January 2012 as a venture partner in the Munich office. He has 13 years experience in the life sciences sector as co-founder, investor and advisor in the area of biotech, medtech, diagnostics and agro biotech. Marc holds a MBA of the University of Stuttgart-Hohenheim (Germany) and after his diploma thesis worked in strategy consulting. In 1999, he co-founded m-phasys, a biotech company active in the production of membrane proteins. He oversaw finance and business development as chief business officer and was i.a. responsible for raising more than EUR 10m venture capital for the company and closing strategic partnerships with e.g. Medarex. In 2003, he joined Bayer Innovation, a corporate development vehicle of Bayer, where he was instrumental in setting up and executing the strategy in medical devices and vaccines. During that time, he co-founded another three companies in diagnostics and medtech, most notably neurovascular medtech comp
Position in the VCSift Database
- • 7 investors at Vesalius Biocapital Partners are tracked.
- • 1,303 investors hold the Managing Partner role in VCSift. Marc Lohrmann is one of them.
- • 845 investors are based in Munich, Bayern, Germany.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Munich, Germany
Contact Information
Find more investors like Marc
Search Investors